Canada Life Sciences Funding
The comprehensive handbook for health innovators. Secure IRAP biotech grants, clinical trial funding, and medical device support.
Top Biotech & MedTech Funding
The go-to initial funding for Canadian biotech startups. Funds technical R&D to overcome scientific uncertainty.
- Up to $500k per project
- Non-Repayable (Grant)
- Covers 60-80% of salary/contractor costs
- Proof of concept studies
- Prototyping medical devices
- Initial validation data
Various streams (CIHR, SIF, Regional) exist to support the high cost of human clinical trials.
Funding to navigate the regulatory hurdle (MDEL, ISO 13485) and scale manufacturing.
Life Sciences Funding Lifecycle
Preclinical & Discovery
Funding Sources: IRAP, NSERC, SR&ED.
Focus on validation data. Grant reviewers need to see "freedom to operate" (IP check) early on.
Regulatory Submission (CTA/MDEL)
Before trials, you need Health Canada approval. Costs for regulatory consultants are often eligible under "export market access" grants if targeting FDA/CE as well.
Clinical Trials (Phase I/II)
Funding Sources: VC equity + SR&ED + Specific Health Funds.
This is the "Valley of Death." Government grants are rarer here; tax credits (SR&ED) become your lifeline.
Market Approval & Scale
Funding Sources: Strategic Innovation Fund (SIF), Regional Agencies.
Focus shifts to biomanufacturing capacity and global sales.
Biotech Winning Strategies
Don't just show the tech works. Show you know exactly what Health Canada/FDA requires. A clear regulatory roadmap instills confidence in funders.
Biotech has the highest SR&ED success rate. Ensure you are tracking "clinical uncertainties" as technological obstacles to maximize your claim.
Life Sciences FAQs
Is software considered a medical device?
It can be. "Software as a Medical Device" (SaMD) requires regulatory approval if it diagnoses or treats conditions. Funding is available for this validation.
Can I use grant money for patent costs?
Some "Market Access" or "Export" grants cover IP legal fees for foreign filings. R&D grants (IRAP) typically do not cover IP legal costs directly.
What about natural health products?
Natural Health Products (NHPs) have a different regulatory pathway than drugs but are still eligible for agri-food or general innovation grants.
Common Questions About Life Sciences Funding
1. Do I need Health Canada approval first?
Not for early R&D funding (like IRAP). However, for clinical trial funding, you typically need your "No Objection Letter" (NOL) or Clinical Trial Application (CTA) approval from Health Canada before funds are released.
2. What is the Clinical Trials Fund (CTF)?
The CTF is part of Canada's Biomanufacturing and Life Sciences Strategy. It is administered by CIHR and funds the "clinical" portion of development, which is often the most expensive gap in the pipeline.
3. Can I use money for IP legal fees?
Generally, no. Technical grants cover science, not lawyers. However, export-focused grants (like CanExport Innovation) may cover IP protection costs if they are required to enter a foreign market.
4. Does SR&ED apply to failed trials?
Yes! SR&ED rewards technological uncertainty, not commercial success. A failed clinical trial often proves that a hypothesis was incorrect, which is valid scientific knowledge and fully claimable.
5. Is there funding for digital health apps?
Yes, if there is a technical hurdle (e.g., AI algorithms, encryption, hardware integration). If it is just a standard app content wrapper, it might not qualify for R&D grants but could qualify for the CDAP digital adoption grant.
6. What about biomanufacturing?
The Strategic Innovation Fund (SIF) has a specific stream for biomanufacturing to increase domestic capacity for vaccine and therapeutic production.
Commercialize Your Discovery
From bench to bedside. Our experts help you navigate the complex funding landscape for life sciences.
Get Biotech Funding Help